DYNAMICS OF PLASMA LEVELS OF LIPOPROTEIN(A), PCSK9, AND THEIR COMPLEX AFTER A SINGLE INJECTION OF EVOLOCUMABATHEROSCLEROSISIF5.72019-08-010PREAI
Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemiaATHEROSCLEROSISIF5.72018-10-0118PREAI
IGM AUTOANTIBODIES AGAINST LIPOPROTEIN(A) AS AN ANTI-ATHEROGENIC FACTOR IN PATIENTS WITH SEVERE HYPERLIPIDEMIAATHEROSCLEROSISIF5.72018-08-010PREAI
EFFECT OF NIACIN ON LIPOPROTEIN SUBFRACTIONS CONCENTRATION IN PATIENTS WITH ELEVATED LIPOPROTEIN(A)ATHEROSCLEROSISIF5.72016-09-010PREAI
HDL AND LDL SUBFRACTIONS AND CORONARY ATHEROSCLEROSIS IN ADULT MALESATHEROSCLEROSISIF5.72015-07-011PREAI
LIPOPROTEIN(A) AND SMALL DENSE LOW DENSITY LIPOPROTEIN SUBFRACTIONS AS CARDIOVASCULAR RISK FACTORSATHEROSCLEROSISIF5.72015-07-010PREAI
LIPOPROTEINS SUBFRACTIONS DISTRIBUTION IN MEN WITH CORONARY ATHEROSCLEROSIS TAKING STATIN THERAPYATHEROSCLEROSISIF5.72014-08-010PREAI